Pharmaceutical pricing: what is reasonable? methodsNTvG Aug 18 Written by Matthijs Versteegh Methods Matthijs Versteegh Previous Previous Ravulizumab for paroxysmal nocturnal haemoglobinuria: a Single Technology Assessment Next Next Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
Pharmaceutical pricing: what is reasonable? methodsNTvG Aug 18 Written by Matthijs Versteegh Methods Matthijs Versteegh
